Vinpocetine: Enhanced Blood Flow to Your Brain


Vinpocetine is a little mentioned nootropic that enhances cognitive function and learning via increasing blood flow to the brain.

Over the past few months since jumping down the nootropics rabbit hole, we’ve covered some of the most popular, and frequently encountered, ingredients including tyrosine, and choline. But, there’s additional mainstream nootropics that don’t get the attention they deserve, yet should have a place alongside the cholines and noopepts of the world.

Today, we turn the spotlight onto Vinpocetine, a rather understated smart drug that improves cognitive function much differently than most of the other well-known nootropics.

We’ve got all the details ahead as we venture forth to learn more about this intriguing supplement!

Vinpocetine – Deals and Price Drop Alerts

Get Price Alerts

No spam, no scams.

Disclosure: PricePlow relies on pricing from stores with which we have a business relationship. We work hard to keep pricing current, but you may find a better offer.

Posts are sponsored in part by the retailers and/or brands listed on this page.

What is Vinpocetine?

Vincamine Structure

Here’s the parent compound Vincamine, from which vinpocetine is derived.

Vinpocetine is a synthetic alkaloid derived from Vincamine, the main compound of the lesser periwinkle plant, Vinca minor L.[1] The compound was first isolated in 1975 by chemist Csaba Szántay and was vinpocetine was first manufactured in 1978 by a Hungarian drug company called Gedeon Richter under the brand name Cavinton.[2]

Following its release, vinpocetine was prescribed in numerous European countries as well as Russia, Mexico, and Japan to treat various cognitive and circulatory brain disorders. In the U.S. and Canada, however, vinpocetine is sold as an over-the-counter supplement and can be used as an ingredient in supplement formulas.

Historically, vinpocetine has been used in Europe as a means to enhance cerebral blood flow in the treatment of epilepsy, stroke recovery, and cognitive decline. In modern times, the synthetic compound has been embraced by the smart drug community as a cognitive and memory enhancer.

Let’s dig a little deeper into this little known nootropic and see what it does that might enhance brain function!

What does Vinpocetine do?

The simple explanation of what vinpocetine does is that it increases blood flow to the brain. With increased blood flow, you get more oxygen and nutrients delivered to the brain thereby increasing cognition, memory, and concentration.

Vinpocetine Inhibits Diagram

Schematic diagram depicting how vinpocetine inhibits NF-κB–dependent inflammatory response in vitro and in vivo. As indicated, vinpocetine inhibits NF-κB–dependent inflammatory response by directly targeting IKK, independent of its well-known action on PDE-1, Na+, and Ca2+ regulation.[10]

The more complicated explanation is that vinpocetine performs a number of actions upon entering your system which begins with the inhibition of phosphodiesterase 1 (PDE1). Research has shown that PDE1 inhibitors have inherent cognitive-enhancing as well as cardioprotective benefits.[3,4] Another benefit of inhibiting PDE1, is increased cGMP concentrations, which is believed to be the reason for vinpocetine’s vasodilating abilities.[5,26]

That’s not all vinpocetine does though, it also affects the flow of certain ions at the cellular level, including:

  • Inhibiting “L-type” calcium channels[6,7]
  • Inhibiting sodium channels[5]
  • Slowing down net potassium channel flow[8]
  • Inhibiting adenosine reuptake[26]

The result of these ion channel interactions is reduced neurotransmitter release, more specifically dopamine and glutamate. By suppressing the release of these neurotransmitters, neuroprotection occurs as a result of decreased oxidative damage.[9]

Vinpocetine may also reduce assorted inflammatory processes in the body by inhibiting IKK-β activation as well as the transfer of NF-kB (a protein complex that controls DNA transcription and cell survival) across cell membranes.[10] FYI, IKK-β is a catalytic subunit of IkB kinase (IKK), a complex that serves as the master regulator for NF-kB activation.[11]

Finally, vinpocetine interacts with alpha adrenergic receptors and the Translocator protein (TPSO) receptor, but, researchers have yet to identify if these interactions impart any effects in the brain.[12]

Now let’s get to the part you’re really here for — how vinpocetine benefits your brain function!

Benefits of Vinpocetine

  • Increases cerebral blood flow

    Vinpocetine Sodium

    Vinpocetine prevents increases in sodium via inhibition of Na+ channels, highlighting one of its many actions in the body.[6]

    Starting off with the most obvious benefit, and the reason for all the others to follow is the increased blood flow vinpocetine provides to the brain. In vitro studies using 20mg vinpocetine resulted in a 7% increase in blood flow to the brain in men,[13] and this improved blood flow is associated with neuroprotection.[14]

    A separate study found that infusion of the same 20mg dose of vinpocetine improved blood flow in stroke victims without impacting blood pressure.[15] Vinpocetine also enhances microcirculation in the brain, by reducing blood viscosity.[16,17]

    Studies administering 30-45mg of vinpocetine orally noted improvements in brain oxygenation in subjects with circulation issues.[18]

  • Boosts Cognitive Power

    A 16 week trial investigated the effects of ingestion of 30 mg of vinpocetine per day, 60 mg of vinpocetine per day or placebo on cognitive performance.

    At the conclusion of the trial, both groups consuming vinpocetine demonstrated significant improvements in cognitive performance compared to placebo, but there was no substantial difference in performance between those taking 30mg and 60mg per day,[19] which suggest that the upper limit for vinpocetine’s benefits might be around 30mg / day, but more on dosing later!

  • Enhances Memory

    Vinpocetine Error Chart

    Notice how the number of errors goes down dramatically following administration of Vinpocetine.[38]

    In an interesting rat study, researchers intentionally stunted hippocampus function and long-term memory potentiation by damaging neurons in the mice brains, but following administration of vinpocetine, the rodents memory and Long-Term Potentiation (LTP) were restored.[20]

    In humans, ingestion of 40mg/day of vinpocetine has been shown to improve memory and memory scanning speed.[21] Researchers believe this is due to LTP and by inhibition of the sodium and calcium ion channels discussed previously.[22,23,24,26]

  • Slows Cognitive Decline

    In a study that administered one week of vinpocetine intravenously, followed by 90 days of oral dosing at 30mg/day documented significant improvements in subjects with symptoms of cognitive decline.[25]

    Another study gave elderly patients a combination of vinpocetine and piracetam to measure its impact on the subjects’ low brain blood flow. Results showed that administration of the treatment slowed the rate of cognitive decline and improved subjective measures of well-being improved.[27]

  • Increases Reaction Time

    Vinpocetine Reaction Time

    Vinpocetine significantly enhances reaction time in healthy individuals.[21]

    Vinpocetine might also enhance your reaction time, which might be of particular interest for the gamers and athletes reading this. A study in women found that consuming 80mg of Vinpocetine per day significantly reduced reaction times from 610ms to 430ms.[21]

  • Improves Mitochondrial Function

    Various studies have shown that vinpocetine can reduce the loss of mitochondrial membrane potential, which is needed to generate ATP, brought on by excitotoxicity.[28] Additionally, it can reverse the drop in mitochondrial function induced by beta-amyloid pigmentation.[29]

  • Reduce Headaches

    Since vinpocetine can increase blood flow to the brain without affecting blood pressure in the body, it’s believed the smart drug may be useful for treating headaches brought on by excessive pressure.[30] Plus, vinpocetine also blocks certain sodium channels which are associated with pain[31], giving you two different mechanisms by which this nootropic can combat headaches.

Other Benefits of Vinpocetine

Vinpocetine Inhibits IKK

Vinpocetine (Vinp) inhibits TNF-α–induced NF-κB activation by targeting IKK.[10]

Various other studies have found that vinpocetine also imparts a number of benefits outside of the cognitive world. Since the focus of this piece is on the nootropic side of vinpocetine, we’ll just list those benefits without getting too detailed on them:

  • Reduce inflammation
  • Inhibit tumor growth
  • Decrease arterial plaque
  • Improve liver function
  • Protect hearing


No “ideal” dose has been identified for vinpocetine, but some help can be found in the Physicians’ Desk Reference for Nutritional Supplements which recommends doses of 5-20 mg/day.[1] Other studies have gone as high as 80mg / day in humans, broken into two-40mg doses.

NutraBio Vinpocetine

Sorry, this one’s been discontinued

When ingested orally, vinpocetine exhibits a half-life ranging from 1.73 to 2.9 hours[1], and has shown an affinity for certain regions of the brain, the thalamus, visual cortex, putamen and basal ganglia in particular.[1]

Ultimately, we’re thinking 30mg/day total is a good place to be.

Best Vinpocetine Supplements

There aren’t a ton of trusted manufacturers out there making Vinpocetine supplements, but there are at least a couple we can trust. They’re shown in the price comparison widgets below.

Vinpocetine – Deals and Price Drop Alerts

Get Price Alerts

No spam, no scams.

Disclosure: PricePlow relies on pricing from stores with which we have a business relationship. We work hard to keep pricing current, but you may find a better offer.

Posts are sponsored in part by the retailers and/or brands listed on this page.

Toxicity and Side Effects

The lethal oral dose (LD50s) for mice and rats is 534 and 503 mg/kg, respectively.[1] Administration of the toxic doses resulted in ataxia and clonic convulsions. As for humans, vinpocetine seems to be pretty safe stuff. Various studies have used doses as high as 60-80mg / day and patients have not experienced any serious adverse side effects.

However, there are some possible side effects including nausea, headaches, sleep disturbances, dizziness, and flushing of the face.

Bioavailability a concern?

Vinpocetine Delivery

Vinpocetine’s bioavailability is significantly increased when paired with a delivery technology or meal.[34]

Vinpocetine has a significantly higher bioavailability in mice than humans, about 52% in rodents. Compare that to humans consuming vinpocetine as part of a water-based solution which has shown a bioavailability of 6.2-6.7%[32], and you might start to think that this smart drug isn’t all that effective. However, consuming vinpocetine with a meal as opposed to being fasted significantly increases its bioavailability by 60-100%![33]

Additionally, using delivery systems, such as liposomal delivery, can increase absorption of vinpocetine[34,35], as can using a topical vinpocetine patch.[36] Regardless, vinpocetine can cross the blood-brain barrier (BBB)[37], it just might help to take it with a meal for maximum efficacy.


Since vinpocetine works a bit differently than most other nootropics, in that it doesn’t directly increase levels of acetylcholine, serotonin, etc, stacking recommendations are a little vaguer.

Realistically speaking, you could probably add it to any nootropic stack for the benefits of increased blood flow, which will just serve to enhance the various actions of other nootropics. The obvious beginning choices are a good form of choline (like citicoline or Alpha-GPC) and L-Tyrosine, before getting into any of the more aggressive stuff.


How about that for a different spin on nootropics?

Vinpocetine offers a wide variety of benefits to cognitive function and health, yet it still doesn’t get the respect it should in the nootropic community. If you’re looking to boost memory, eliminate brain fog, and enhance overall brain function, give vinpocetine a shot next time you’re looking to dabble in the world of nootropics.

Vinpocetine – Deals and Price Drop Alerts

Get Price Alerts

No spam, no scams.

Disclosure: PricePlow relies on pricing from stores with which we have a business relationship. We work hard to keep pricing current, but you may find a better offer.

Posts are sponsored in part by the retailers and/or brands listed on this page.

About the Author: Mike Roberto

Mike Roberto

Mike Roberto is a research scientist and water sports athlete who founded PricePlow. He is an n=1 diet experimenter with extensive experience in supplementation and dietary modification, whose personal expertise stems from several experiments done on himself while sharing lab tests.

Mike's goal is to bridge the gap between nutritional research scientists and non-academics who seek to better their health in a system that has catastrophically failed the public. Mike is currently experimenting with a low Vitamin A diet.

4 Comments | Posted in , | Tagged , , , , , , .


  2. Lorincz C, Szasz K, Kisfaludy L. The synthesis of ethyl apovincaminate. Arzneimittelforschung. 1976;26(10a):1907.
  3. Ahn HS, Crim W, Romano M, Sybertz E, Pitts B. Effects of selective inhibitors on cyclic nucleotide phosphodiesterases of rabbit aorta. Biochem Pharmacol. 1989;38(19):3331-3339.
  4. Hagiwara M, Endo T, Hidaka H. Effects of vinpocetine on cyclic nucleotide metabolism in vascular smooth muscle. Biochem Pharmacol. 1984;33(3):453-457.
  5. Bonoczk P, Gulyas B, Adam-Vizi V, et al. Role of sodium channel inhibition in neuroprotection: effect of vinpocetine. Brain Res Bull. 2000;53(3):245-254.
  6. Tretter L, Adam-Vizi V. The neuroprotective drug vinpocetine prevents veratridine-induced [Na+]i and [Ca2+]i rise in synaptosomes. Neuroreport. 1998;9(8):1849-1853.
  7. Kaneko S, Takahashi H, Satoh M. The use of Xenopus oocytes to evaluate drugs affecting brain Ca2+ channels: effects of bifemelane and several nootropic agents. Eur J Pharmacol. 1990;189(1):51-58.
  8. YuV B, Solntseva EI. Nootropic agent vinpocetine blocks delayed rectified potassium currents more strongly than high-threshold calcium currents. Neurosci Behav Physiol. 1998;28(2):116-120.
  9. Sitges M, Nekrassov V. Vinpocetine selectively inhibits neurotransmitter release triggered by sodium channel activation. Neurochem Res. 1999;24(12):1585-1591.
  10. Jeon K-I, Xu X, Aizawa T, et al. Vinpocetine inhibits NF-κB–dependent inflammation via an IKK-dependent but PDE-independent mechanism. Proceedings of the National Academy of Sciences of the United States of America. 2010;107(21):9795-9800. doi:10.1073/pnas.0914414107.
  12. Gulyas B, Halldin C, Sandell J, et al. PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects. Acta Neurol Scand. 2002;106(6):325-332.
  13. Lim CC, Cook PJ, James IM. The effect of an acute infusion of vincamine and ethyl apovincaminate on cerebral blood flow in healthy volunteers. British Journal of Clinical Pharmacology. 1980;9(1):100-101.
  14. Kemeny V, Molnar S, Andrejkovics M, Makai A, Csiba L. Acute and chronic effects of vinpocetine on cerebral hemodynamics and neuropsychological performance in multi-infarct patients. J Clin Pharmacol. 2005;45(9):1048-1054. doi:10.1177/0091270005279363.
  15. Bonoczk P, Panczel G, Nagy Z. Vinpocetine increases cerebral blood flow and oxygenation in stroke patients: a near infrared spectroscopy and transcranial Doppler study. Eur J Ultrasound. 2002;15(1-2):85-91.
  16. Kuzuya F. Effects of vinpocetine on platelet aggregability and erythrocyte deformability. Ther Hung. 1985;33(1):22-34.
  17. Osawa M, Maruyama S. Effects of TCV-3B (vinpocetine) on blood viscosity in ischemic cerebrovascular diseases. Ther Hung. 1985;33(1):7-12.
  18. Szobor A, Klein M. Ethyl apovincaminate therapy in neurovascular diseases. Arzneimittelforschung. 1976;26(10a):1984-1989.
  19. Hindmarch I, Fuchs HH, Erzigkeit H. Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes. Int Clin Psychopharmacol. 1991;6(1):31-43.
  20. Molnar P, Gaal L, Horvath C. The impairment of long-term potentiation in rats with medial septal lesion and its restoration by cognition enhancers. Neurobiology (Bp). 1994;2(3):255-266.
  21. Subhan Z, Hindmarch I. Psychopharmacological effects of vinpocetine in normal healthy volunteers. Eur J Clin Pharmacol. 1985;28(5):567-571.
  22. Ishihara K, Katsuki H, Sugimura M, Satoh M. Idebenone and vinpocetine augment long-term potentiation in hippocampal slices in the guinea pig. Neuropharmacology. 1989;28(6):569-573.
  23. Tóth E, Kiss B, Gere A, et al. 1-Oxa-3,8-diazaspiro[4.5]decan-2-one derivatives with a potent inhibitory effect on neural Ca-uptake and protecting action against TET-induced brain edema and memory and learning deficits. Eur J Med Chem. 1997;32(1):27-38. doi:
  24. Paroczai M, Kiss B, Karpati E. Effect of RGH-2716 on learning and memory deficits of young and aged rats in water-labyrinth. Brain Res Bull. 1998;45(5):475-488.
  25. Chukanova EI. [Efficacy of cavinton in the treatment of patients with chronic blood flow insufficiency. Russian multicenter clinical-epidemiological program “CALIPSO”]. Zhurnal Nevrol i psikhiatrii Im SS Korsakova. 2010;110(12):49-52.
  26. Kiss B, Karpati E. [Mechanism of action of vinpocetine]. Acta Pharm Hung. 1996;66(5):213-224.
  27. Vorob’eva O V, Tamarova ES. [Efficacy of vinpotropile in the therapy of initial signs of cerebrovascular pathology]. Zhurnal Nevrol i psikhiatrii Im SS Korsakova. 2010;110(9):39-42.
  28. Tarnok K, Kiss E, Luiten PGM, et al. Effects of Vinpocetine on mitochondrial function and neuroprotection in primary cortical neurons. Neurochem Int. 2008;53(6-8):289-295. doi:10.1016/j.neuint.2008.08.003.
  29. Pereira C, Agostinho P, Oliveira CR. Vinpocetine attenuates the metabolic dysfunction induced by amyloid beta-peptides in PC12 cells. Free Radic Res. 2000;33(5):497-506.
  30. Alkuraishy HM, Al-Gareeb AI, Albuhadilly AK. Vinpocetine and Pyritinol: A New Model for Blood Rheological Modulation in Cerebrovascular Disorders—A Randomized Controlled Clinical Study. BioMed Research International. 2014;2014:324307. doi:10.1155/2014/324307.
  31. Molnár P, Erdő SL. Vinpocetine is as potent as phenytoin to block voltage-gated Na+ channels in rat cortical neurons. Eur J Pharmacol. 1995;273(3):303-306. doi:
  32. Szakacs T, Veres Z, Vereczkey L. In vitro-in vivo correlation of the pharmacokinetics of vinpocetine. Pol J Pharmacol. 2001;53(6):623-628.
  33. Lohmann A, Dingler E, Sommer W, Schaffler K, Wober W, Schmidt W. Bioavailability of vinpocetine and interference of the time of application with food intake. Arzneimittelforschung. 1992;42(7):914-917.
  34. Cui S-X, Nie S-F, Li L, Wang C-G, Pan W-S, Sun J-P. Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine. Drug Dev Ind Pharm. 2009;35(5):603-611. doi:10.1080/03639040802488089.
  35. Xu H, He L, Nie S, et al. Optimized preparation of vinpocetine proliposomes by a novel method and in vivo evaluation of its pharmacokinetics in New Zealand rabbits. J Control Release. 2009;140(1):61-68. doi:10.1016/j.jconrel.2009.07.014.
  36. El-Laithy HM, Shoukry O, Mahran LG. Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. Eur J Pharm Biopharm. 2011;77(1):43-55. doi:10.1016/j.ejpb.2010.10.011.
  37. Gulyas B, Halldin C, Karlsson P, et al. Brain uptake and plasma metabolism of [11C]vinpocetine: a preliminary PET study in a cynomolgus monkey. J Neuroimaging. 1999;9(4):217-222.
  38. Ogunrin A. Effect of Vinpocetine (CognitolTM) on Cognitive Performances of a Nigerian Population. Annals of Medical and Health Sciences Research. 2014;4(4):654-661. doi:10.4103/2141-9248.139368.

Comments and Discussion (Powered by the PricePlow Forum)